Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
Pharmaceutical Technology
APRIL 4, 2025
The EC has approved Daiichi Sankyo and AstraZenecas Enhertu for use as a single agent to treat adults with certain breast cancers.
Fri.Apr 04, 2025
274 
Trial monitors recommend Elevidys studies continue; Novartis kidney drug approved
Bio Pharma Dive
APRIL 4, 2025
Sarepta and Roche will share the monitors' findings with EMA to resolve a temporary hold. Elsewhere, Allakos agreed to a buyout and high-dose Ocrevus missed a study goal.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Streeting promises UK pharma quick action on VPAG frustration
Pharmaceutical Technology
APRIL 4, 2025
Streeting said his June 10-year plan will address drug sale clawbacks, NICE regulation, and the abolition of NHS England.
Tariffs send healthcare industry into ‘unchartered waters’
Bio Pharma Dive
APRIL 4, 2025
Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, threatening to create disruptions to patient care.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Scientists cast new light on how fasting impacts the immune system
Medical Xpress
APRIL 4, 2025
New research from The University of Manchester may reshape our understanding of what happens to the immune system when we fast. The study on mice shows that the brain's hypothalamus controls how the immune system adapts during fasting, through a handful of highly specialized neurons responsible for making animals hungry.
M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals
Bio Pharma Dive
APRIL 4, 2025
Just two acquisitions in the first quarter, that of Intra-Cellular Therapies and IDRx, crossed the $1 billion mark, a notable decrease from the six seen during the same period last year.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Uveitis market expected to reach $1.5bn across 7MM by 2033
Pharmaceutical Technology
APRIL 4, 2025
Late-stage pipeline products anticipated to reach the uveitis market during the forecast period will introduce new mechanisms of action.
Platform-predicted treatments improve outcomes for platinum-resistant ovarian cancer
Medical Xpress
APRIL 4, 2025
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for patients with platinum-resistant ovarian cancer.
NBE Therapeutics opens ADC research facility in Switzerland
Pharmaceutical Technology
APRIL 4, 2025
Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-drug conjugates (ADC) R&D facility in Basel, Switzerland.
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
Medical Xpress
APRIL 4, 2025
Collaborative research led by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center defines a novel approach to understanding how certain proteins called transcription factors determine which genetic programs will drive cell growth and maturation. The study is published in the journal Science.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditions
Pharmaceutical Technology
APRIL 4, 2025
Sanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administrations (FDA) orphan drug designation.
Uplizna is first drug FDA-cleared for rare disease IgG4-RD
pharmaphorum
APRIL 4, 2025
Amgen has bagged a second indication for its B cell-depleting therapy Uplizna after the FDA cleared it for rare inflammatory disease IgG4-RD
Digital cognitive assessments and blood-based biomarkers in Alzheimer’s research
Pharmaceutical Technology
APRIL 4, 2025
Dementia affects millions of people worldwide, causing a serious impact on the economy and the healthcare system.
Planetary health diet and Mediterranean Diet associated with similar survival and sustainability benefits
Medical Xpress
APRIL 4, 2025
Two plant-based diets were associated with similar survival benefits and low environmental impact, according to research presented at European Society of Cardiology (ESC) Preventive Cardiology 2025.
Harnessing zero‑party data: Transforming pharma advertising for better patient engagement
pharmaphorum
APRIL 4, 2025
Harness the power of zero-party data in pharma advertising to enhance patient engagement. Discover how a strategic brand strategy can transform your approach in this industry.
Good diagnostic accuracy found in Swedish National Patient Register
Medical Xpress
APRIL 4, 2025
The Swedish National Patient Register (NPR) has long been a cornerstone for epidemiological research. Researchers at Karolinska Institutet have published a new review examining the validity of the register and found that it is good for most diagnoses and very good for surgical procedures.
MoonLake secures $500m for lead drug, plus other financings
pharmaphorum
APRIL 4, 2025
MoonLake secures $500m in financing for lead inflammatory disease drug sonelokimab while AIRNA, Atsena, and Neurona complete $100m+ private rounds
Siemens Inks $5.1 Billion Deal for Dotmatics
Pharmaceutical Commerce
APRIL 4, 2025
The parties aim to create an end-to-end digital thread that links research data all the way through to life sciences manufacturing.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Pulse 4/4/25: The ‘Healthy Immigrant Effect’, Google Gemini, AI Commercialization in Pharma & more
Pharmaceutical Commerce
APRIL 4, 2025
The latest news for pharma industry insiders.
Paige's cancer detection AI gets FDA breakthrough status
pharmaphorum
APRIL 4, 2025
Paige has been awarded breakthrough device status from the FDA for an AI tool that can be used to detect cancer across different areas of the body.
Reasons Behind the Rising Popularity of DTC Online Prescription Services
Pharmaceutical Commerce
APRIL 4, 2025
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirsts chief medical officer, uncovers the main reasons why 52% of respondents choose DTC online prescription platforms.
How pharma is tackling new direct-to-patient programmes
pharmaphorum
APRIL 4, 2025
How pharma is tackling new direct-to-patient programmes Jonah.
A smart wearable for ear-based high-precision health sensing
Medical Xpress
APRIL 4, 2025
Wearables such as smartwatches, fitness trackers, or data glasses have become an integral part of our everyday lives. They record health data, monitor your sleep, or calculate your calorie consumption.
AZ grabs pair of EU approvals for top cancer drugs
pharmaphorum
APRIL 4, 2025
AstraZeneca is celebrating two approvals for cancer drugs Imfinzi and Enhertu in the EU as it faces increased competition to its top-seller Tagrisso.
Alteplase increases frequency of functional independence after posterior circulation stroke
Medical Xpress
APRIL 4, 2025
For patients with mainly mild posterior circulation ischemic stroke who do not receive thrombectomy, alteplase administered at 4.5 to 24 hours after onset results in higher frequency of functional independence at 90 days compared with standard medical care, according to a study published in the April 3 issue of the New England Journal of Medicine.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Direct-to-patient is more than just telehealth – with EVERSANA’s Faruk Abdullah
pharmaphorum
APRIL 4, 2025
Hear from EVERSANA's Faruk Abdullah in this video interview as he explains why direct-to-patient strategies go beyond telehealth. Discover the latest insights and trends in the industry.
Signs that precede sudden arrhythmic death syndrome in young people
Medical Xpress
APRIL 4, 2025
Recognizing and detecting the signs that commonly precede sudden arrhythmic death syndrome (SADS) may help to prevent premature deaths, according to research presented today at ESC Preventive Cardiology 2025, a scientific congress of the European Society of Cardiology (ESC).
4th Liquid Biopsy for Precision Oncology East Coast
pharmaphorum
APRIL 4, 2025
4th Liquid Biopsy for Precision Oncology East Coast Sara.
Outdoor time and multisport activities can help develop children's motor competence
Medical Xpress
APRIL 4, 2025
A study conducted by the Faculty of Sport and Health Sciences at the University of Jyvskyl, Finland, followed the development of children's motor skills over a three-year period, from early childhood education to school age. The study showed that independent outdoor time and multisport activities support the development of motor competence. Even 30 minutes of outdoor time after a day at childcare makes a difference.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content